• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Novo Nordisk to Acquire Emisphere Technologies contractpharma
    November 16, 2020
    ​Novo Nordisk entered into a definitive agreement to acquire Emisphere Technologies Inc., a drug delivery company, for $1.35 billion.
  • NMPA approves oral formulation of Akynzeo in China biospectrumasia
    September 25, 2019
    Riccardo Braglia, Helsinn Group Vice Chairman and CEO commented: "Lack of control of CINV is a problem despite the availability of several antiemetics. We are pleased that Akynzeo® that targets two CINV critical pathways in a single dose will help patient
  • Shield’s Feraccru accepted for review in the US pharmatimes
    December 06, 2018
    Shield Therapeutics’ iron deficiency drug Feraccru has been accepted for review by the US Food and Drug Administration (FDA).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service